Overall, Edwards enjoys a great deal of financial flexibility that would allow for more substantial acquisitions, if those opportunities were to arise. Edwards Lifesciences has come to dominate ...

Cardiovascular disease (CVD) is a broad term for many conditions that can affect your heart. Knowing the differences can be ...

Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...

February is American Heart Month, a time to raise awareness of heart conditions and heart healthy lifestyles. Led by the Alliance for Aging Research, on February 22, organizations, advocates, and ...

Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

Rep. John Larson said doctors have since prescribed medication that they say will "greatly reduce the chance of this happening again." ...

As tools become more precise and non-invasive, doctors are able to diagnose and treat heart conditions with greater accuracy and efficiency.

Dr Swetha Bakhru, senior consultant of paediatrics, Rainbow Children’s Heart Institute, said, “Around 10 per cent of the CHD ...

Connecticut U.S. Rep. John Larson, who inexplicably stopped speaking during a speech Monday on the House of Representatives ...

Congenital heart defect is a problem that arises when the heart does not develop normally before birth. On Congenital Heart ...